Jarod Rutledge

Investing

I invest at Starbloom Capital. Selected investments and board roles are listed below.

Adaptyx Bio
Investor
FDA Breakthrough designation for continuous cortisol monitoring Company release ·
Becoming AI
Led pre-seed
A new way to study the miracle of life Core Memory ·
Bexorg
Investor · Board observer
ARPA-H award of up to $28.3 million for human-brain drug research Company release ·
Cognito Therapeutics
Co-led Series C · Board director
Exploratory biomarker findings presented at AAIC Company release ·
Constellation
Led pre-seed and seed
Cyclarity Therapeutics
Co-led Series A · Board director
First human data on oxidized cholesterol excretion Company release ·
LiFT Therapeutics
Led Series A · Board director
Daniel Passeri appointed CEO ahead of planned clinical studies Company release ·
MagIC Lifescience
Led Series A · Board director
Nula Therapeutics
Investor · Board director
Launch with an ARPA-H award of up to $20 million Company release ·